-----
Read the full article: Industry Calls for Changes to FDA’s DSCSA Product Identifier Guidance - RAPS.org
"The biggest change industry is calling for is for FDA to allow manufacturers to use the GS1 Global Trade Identification Number (GTIN), which typically contains the National Drug Code (NDC) number along with other information, in the human-readable portion of the product identifier in place of the NDC. This request is echoed by the Biotechnology Innovation Organization (BIO), the Association for Accessible Medicines, the Healthcare Distribution Alliance, Bristol-Myers Squibb, Shire and GS1 itself.
In its comments, the BIO also asks FDA to revise the guidance to allow manufacturers more flexibility when it comes to ordering the human-readable portion of the product identifier."
You might also be interested in:
ICYMI: FDA Released Three DSCSA-Related Guidances - Healthcare Packaging
Return Home: The Designated Representative and Exemptee Blog
-------------
 |
| California Designated Representative Training Courses (wholesaler, 3PL, reverse distributor) - Approved by the California State Board of Pharmacy |
For Designated Representative license applicants - Training programs, courses, classes, seminars:
California (earn a training affidavit):- CA Designated Representative Wholesaler Training - Available around-the-clock 24 x 7
- CA Designated Representative 3PL Training
- CA Designated Representative Reverse Distributor Training - New!
- The Designated Representative Institute
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.